TNFSF9 and neoplasm: Mice that survived after initial implantation of CT-2A-FLuc-Tnfsf9 or 005-FLuc-Tnfsf9 cells were rechallenged with a second tumor (CT-2A-FLuc and 005-FLuc, respectively).